Objective. To determine the pathological, clinical, and therapeutic factors
which had prognostic significance in women with extraovarian primary perit
oneal carcinoma (EOPPC).
Methods. A retrospective, clinicopathologic study was conducted of 75 women
diagnosed with EOPPC. Diagnosis and assessment of prognostic pathological
factors were based on the Gynecologic Oncology Group (GOG) criteria. Univar
iate and multivariate analyses were used to assess the following factors fo
r their effect on overall survival: age, parity, presenting symptoms and si
gns, ascites, CA 125 level, history of oophorectomy, maximum ovarian dimens
ion, histologic type, architectural and nuclear grades, number of mitosis a
nd psammoma bodies, depth of ovarian invasion, estrogen and progesterone re
ceptors (positive, negative), p53 overexpression (present, absent), perform
ance status (GOG criteria), stage (FIGO criteria for ovarian cancer), debul
king surgery (optimal versus suboptimal), first-line chemotherapy (platin-b
ased without paclitaxel versus platin/paclitaxel), secondary cytoreduction,
and second-line chemotherapy (paclitaxel-based versus no paclitaxel).
Results. The median overall survival of all patients was 23.5 months (95% C
I 18.6, 39.8 months). The 5-year survival was 26.5% (SE 6.7%). p53 overexpr
ession and estrogen and progesterone receptor positivity were demonstrated
in 42.4, 50.0, and 6.3%, respectively. In univariate analysis, performance
status, primary debulking surgery, stage, and age were significant on overa
ll survival (P < 0.001, <0.001, 0.004, and 0.012, respectively). In multiva
riate analysis, only performance status (P < 0.001) and primary debulking s
urgery (P = 0.03) were independent prognostic factors.
Conclusions. Overall survival in women with EOPPC is affected significantly
by performance status and primary debulking surgery as independent variabl
es. To improve survival, efforts should be made to achieve optimal tumor cy
toreduction at primary surgery. (C) 1998 Academic Press.